The association of liver fibrosis and chronic kidney disease in patients with metabolic associated fatty liver disease
Chronic kidney disease may represent a potential risk influence for liver fibrosis development in MAFLD patients.
Authors
- Walaa Elkhalawany (ORCID: https://orcid.org/0000-0003-2316-7615)
- Rehab Badawi (ORCID: https://orcid.org/0000-0002-5235-8819)
- Waleed Elrefaey (ORCID: https://orcid.org/0000-0003-3758-1438)
- Sara Essam Hasby
- Nahla Ahmed Khalf
- Naglaa Samy Fahmy Abou Taira
- Hanaa Ibrahim Okda
Institutions
- Tanta University (EG)
- Tanta University Hospital (EG)
Publication Details
- Journal
- Saudi Medical Journal
- Published
- 2024-10-01
- DOI
- https://doi.org/10.15537/smj.2024.45.10.20240393
- Citations
- 2
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.77